Comac goes global with new executive appointments

Comac Medical, a full-service contract research organization (CRO) based in Bulgaria, has announced major leadership changes alongside an international expansion drive, under the ownership of investment firm EdgeCap Partners.

The company, founded in 1997 in Sofia, said it has appointed Chris Smyth as chief executive, effective September 1. Mr Smyth, who is based in the UK, was previously president of ICON Biotech and held senior positions at IQVIA Biotech.

Comac Medical has also set up a new supervisory board chaired by Neil Ferguson, who has more than 35 years of experience in healthcare and clinical research services. Mr Ferguson previously held senior commercial roles at Syneos Health and Quintiles.